Publications
Search our bibliography using the filters on the right-hand side.
Displaying 201 through 250 of 260 publications.
Skip to main content
Lee LJ, Nelson LM, McLeod LD, Hill CD, Sweeney CT. Effects of insulin therapy on the Diabetes Symptom Checklist-Revised (DSC-R): data from a large insulin clinical trial. Poster presented at the 2009 ISPOR 14th Annual International Meeting; May 21, 2009. [abstract] Value Health. 12(3):A105.
Williams VS, DeMuro-Mercon CJ, Reeve BB, Erder MH. Implementing FDA PRO Guidelines: content validity and good measurement practices — what is the right balance? Presented at the International Society for Pharmacoeconomics and Outcomes Research 14th Annual International Meeting; May 15, 2009. Orlando, FL.
Khan SB, Zagar AJ, Hayes CP, DiBenedetti DB, Zhou X, Price M, Van Brunt DL. Assessment of type 2 Diabetes mellitus patients with and without symptoms of ADHD: patient characteristics and resource utilization data from an internet-based survey. Poster presented at the International Society for Pharmacoeconomics and Outcomes Research 14th Annual International Meeting; May 15, 2009. Orlando, FL. [abstract] Value Health. 2009 May 1; 12(3):A181-2.
Arbuckle R, Atkinson M, Clark MJ, Abetz-Webb L, Lohs J, Kuhagen I, Harness J, Draelos Z, Thiboutot D, Blume-Paytavi U, Copley-Merriman K. Patient experiences with oily skin: the qualitative development of content for two new patient reported outcome questionnaires. Poster presented at the American Academy of Dermatology Meeting; March 1, 2009.
Doward LC, McKenna SP, Whalley D, Tennant A, Griffiths B, Emery P, Veale DJ. The development of the L-QoL: a quality of life instrument specific to systemic lupus erythematosus. Ann Rheum Dis. 2009 Feb;68(2):196-200. doi: 10.1136/ard.2007.086009
Doward LC, McKenna SP, Meads DM, Kahler K, Frech F. The development of the Herpes Symptom Checklist (HSC) and the Herpes Outbreak Impact Questionnaire (HOIQ). Value Health. 2009 Jan 1;12(1):139-45.
Anderson RT, Girman CJ, Pawaskar MD, Camacho FT, Calles J, Kelly WS, DeMuro C, Balkrishnan R. Diabetes medication satisfaction tool: a focus on treatment regimens. Diabetes Care. 2009 Jan 1;32(1):51-3.
Turk DC, Dworkin RH, McDermott MP, Bellamy N, Burke LB, Chandler JM, Cleeland CS, Cowan P, Dimitrova R, Farrar JT, Hertz S, Heyse JF, Iyengar S, Jadad AR, Jay GW, Jermano JA, Katz NP, Manning DC, Martin SA, Max MB, McGrath P, McQuay HJ, Quessy S, Rappaport BA, Revicki DA, Rothman M, Stauffer JW, Svensson O, White RE, Witter J. Analyzing multiple endpoints in clinical trials of pain treatments: IMMPACT recommendations. Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials. Pain. 2008 Oct;139(3):485-93. doi: 10.1016/j.pain.2008.06.025.
Goldberg JF, McLeod LD, Fehnel SE, Hamm LR, Gilchrist K. Development and evaluation of a new patient-reported instrument: the bipolar functional status questionnaire. Poster presented at the 16th European Congress of Psychiatry; April 8, 2008.
Mease PJ, Russell IJ, Arnold LM, Florian H, Young JP, Martin SA, Sharma U. A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia. J Rheumatol. 2008 Mar;35(3):502-14.
Schneeweiss S, Patrick AR, Sturmer T, Brookhart MA, Avorn J, Maclure M, Rothman KJ, Glynn RJ. Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results. Med Care. 2007 Oct 1;45(10 - Suppl 2):S131-42.
Dickinson KL, Pattanayak SK, Yang J, Patil SR, Praharaj P, Mallick RK, Blitstein JL, Poulos C. Nature's call: can social mobilization promote toilet use and reduce child diarrhea? Results from a community randomized trial in Orissa, India. Presented at the Infectious Diseases Conference at Cornell University; September 2007.
Camilleri M, Mangel AW, Fehnel SE, Drossman DA, Mayer EA, Talley NJ. Primary endpoints for irritable bowel syndrome trials: a review of performance of endpoints. Clin Gastroenterol Hepatol. 2007 May 1;5(5):534-40.
Dickinson KL, Pattanayak SK, Yang J, Patil SR, Praharaj P, Mallick RK, Blitstein JL, Poulos C. Nature's call: can a social mobilization campaign lead households to use toilets and reduce diarrhea? Results from a randomized trial in Orissa. Poster presented at the 4th Minnesota International Economic Development Conference at the University of Minnesota; May 2007.
Doward LC, McKenna SP, Meads DM, Jovell AJ, Fisk J, Eckert BJ. The international development of patient reported outcome indices for multiple sclerosis. Poster presented at the 2006 Sixteenth Meeting of the European Neurological Society; May 2006. Lausanne, Switzerland. [abstract] J Neurol. 2006; 253(Suppl 2):125.
DiBenedetti DB, Gondek K, Sagnier PP, Kubin M, Keininger D, Marquis P. The treatment satisfaction scale: a multidimensional instrument for the assessment of treatment satisfaction for erectile dysfunction patients and their partners. Eur Urol. 2005 Sep 1;48(3):503-11.
Stevens KJ, Brazier JE, McKenna SP, Doward LC, Cork MJ. The development of a preference-based measure of health in children with atopic dermatitis. Br J Dermatol. 2005 Aug 1;153(2):372-7.
DiBenedetti DB, Barrett AM, Fehnel SE, Downs KE. The humanistic impact of oral anti-diabetic agents: patients' perspectives. Poster presented at the 65th American Diabetes Association; June 2005.
Schmidt RA, Ackerman SJ, Newstead GM, Quam JP, Mordin MM, Anastassopoulos K, Nishikawa RM. Comparative feature analysis of computed radiography for mammography (CRM) soft copy display vs. crm hard copy film: an observer performance study. Poster presented at the 90th Scientific Assembly and Annual Meeting of the Radiology Society of North America; November 2004.
Eaton SC, Mangel AW, Hollis KA, Ameen VZ, Hamm LR, Andrews EB, Williams RL, Cook SF. Symptoms of diarrhea-predominant or alternating IBS: an exploratory analysis. Poster presented at the 20th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 22, 2004. Bordeaux.
Fehnel SE, Victor T, Manjunath R, Mullen J. Development of a patient-reported instrument to assess the functional status of patients with bipolar disorder. Presented at the ISOQOL 2004 Symposium; June 27, 2004.
Fehnel SE, Victor T, Manjunath R, Sechrest L, Haynes S, Strakowski S. The development of a patient-reported instrument to assess the functional status of patients with bipolar disorder. Presented at the International Society for Quality of Life Research (ISOQOL) 2004 Symposium, Stating the Art: Advancing Outcomes Research Methodology and Clinical Applications; June 1, 2004. Boston, MA.
McKenna SP, Doward LC, Whalley D, Tennant A, Emery P, Veale DJ. The development of the PsAQoL: a quality of life instrument specific to psoriatic arthritis. Ann Rheum Dis. 2004 Feb 1;63(2):162-9.
Rothman KJ. A potential bias in safety evaluation during open-label extensions of randomized clinical trials. Pharmacoepidemiol Drug Saf. 2004 Jan 1;13(5):295-8.
McKenna SP, Doughty N, Pepke-Zaba J, Meads D, Doward LC. Development of patient-reported outcome measures for pulmonary arterial hypertension. Poster presented at the 2003 ISPOR 6th Annual European Congress; November 2003. Barcelona, Spain. [abstract] Value Health. 2003 Nov; 6(6):671.
Doward LC, McKenna SP, Meads DM. Development of the herpes outbreak impact questionnaire (HOIQ). Poster presented at the 2003 ISPOR 6th Annual European Congress; November 2003. Barcelona, Spain. [abstract] Value Health. 2003 Nov; 6(6):760-1.
Doward LC, McKenna SP, Meads DM. Development of the herpes outbreak impact questionnaire (HOIQ). Poster presented at the 10th Annual Conference of the International Society for Quality of Life Research (ISQOL); November 2003. [abstract] Qual Life Res. 2003 Nov; 12(7):862.
Quam JP, Ackerman SJ, Mordin MM, Bassett LW. Conspicuity and characterization of findings on computed radiography for mammography vs. screen-film mammography: results from a prospective clinical trial. Poster presented at the 89th Scientific Assembly and Annual Meeting of the Radiology Society of North America; November 2003.
DeMuro-Mercon CJ, Gonce C, Lewis SA, Altarac D, O'Keefe S, Bachmann S. The electronic patient reported outcome (e-PRO): compliance procedures and regulatory applicability. Poster presented at the Drug Information Association; October 2003.
Trump DL, Wilding G, Miller K, Small E, Soulie P, Trachtenberg J, Raabe N, Heyes AE, Das-Gupta A. Pilot trials of ZD1839 ('Iressa'), an orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor, in combination with mitoxantrone/prednisolone or docetaxel/estramustine in patients with hormone-refractory prostate cancer. Presented at the American Urology Association; April 2003. Chicago, IL.
Ellis CN, Mordin MM, Adler EY. Effects of alefacept on health-related quality of life in patients with psoriasis: results from a randomized, placebo-controlled phase II trial. Am J Clin Dermatol. 2003 Feb 1;4(2):131-9.
Doward LC, Spoorenberg A, Whalley D, Cook SA, Helliwell PS, Kay LJ, McKenna SP, Tennant A, van der Heijde D, Chamberlain MA. Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis. Ann Rheum Dis. 2003 Jan 1;62(1):20-6.
McLeod LD, Fehnel SE, Brandman J, Symonds T. Evaluating minimal clinically important differences for the acne-specific quality of life questionnaire. Pharmacoeconomics. 2003 Jan 1;21(15):1069-79.
DeMuro-Mercon CJ, Lewis SA, Gonce C. Old relationships, new technologies: partnering with your clinical sites to make an electronic patient reported outcome (e-PRO) work for diary and questionnaire data. Poster presented at the Drug Information Association; 2003.
Nadjar A, Martin AR, Giroudet C, Lewis S, Conway K, Lindley C, Olver I. Multi-national phase III trials of aprepitant for the prevention of cinv: translation and linguistic validation of an emesis diary and patient questionnaire into 22 languages. Presented at the 2003 American Society of Clinical Oncology Annual Meeting, Abstract No. 3158; January 1, 2003. Chicago, IL.
Lovas K, Kalo Z, McKenna SP, Whalley D, Pentek M, Genti G. Establishing a standard for patient-completed instrument adaptations in Eastern Europe: experience with the Nottingham Health Profile in Hungary. Health Policy (New York). 2003 Jan 1;63(1):20.
Fehnel SE, McLeod LD, Brandman J, Arbit DI, McLaughlin-Miley CJ, Coombs JH, Martin AR, Girman CJ. Responsiveness of the acne-specific quality of life questionnaire (Acne-QoL) to treatment for acne vulgaris in placebo-controlled clinical trials. Qual Life Res. 2002 Dec 1;11(8):809-16.
Watts (Wideman) KB, McAvinchey G, Ladner A. Demographic characteristics as indicators of performance on the Spanish language skills assessment. Poster presented at the 21st Annual Conference of the Southern Association for Public Opinion Research; October 2002. Raleigh, NC.
Hollis KA, Duffer A. The use of panels as an effective means of collecting patient-reported outcomes. Presented at the Drug Information Association's 9th Annual Symposium for Quality of Life Evaluation; March 2002.
Menter A, Gottlieb A, Griffiths C, Mordin MM. Health-related quality of life impact of weekly intravenous or intramuscular alefacept in patients with psoriasis: results from two randomized, placebo-controlled phase III trials. Poster presented at the Annual Meeting of the American Academy of Dermatology; February 2002.
Gilsenan AW. Development of a minimum dataset (MDS)-based comorbidity index for a nursing home population. Poster presented at the Fourth International Society for Pharmacoeconomics and Outcomes Research Congress; 2001. [abstract] Value Health. 2001 Sep; 4(6):417-8.
Buchner DA, Graboys TB, Johnson K, Mordin MM, Goodman L, Partsch DS, Goss TF. Development and validation of the ITG Health-Related Quality-of- Life Short-Form measure for use in patients with coronary artery disease. Integrated Therapeutics Group. Clin Cardiol. 2001 Aug;24(8):556-63.
Doward LC, Whalley D, McKenna SP. The development of the Alzheimer's Carers Quality of Life Instrument (ACQLI). Proc Br Psychol Soc. 2001;9(1):65.
Pendergast KB, West SL, Gilsenan AW, Swindle R, Kroenke K. Development of a suicidal assessment algorithm for telephone interviewers. Poster presented at the 16th International Conference on Pharmacoepidemiology; August 2000.
Neighbors DM, Candrilli SD. Concomitant medication costing using clinical trial data: a case study. Presented at the 2000 ISPOR 5th Annual International Meeting; May 2000. Arlington, VA.
McKenna SP, Cook SA, Whalley D, Doward LC, Niero M, Erdman RA. The development of the PSORIQoL: a quality of life measure specific to psoriasis. Poster presented at the 7th Annual Conference of the International Society for Quality of Life Research (ISOQOL); October 2000. Vancouver, Canada. [abstract] Qual Life Res. 2000 Mar; 9(3):322.
Steffensen FH, Sorensen HT, Gillman MW, Rothman KJ, Sabroe S, Fischer P, Olsen J. Low birth weight and preterm delivery as risk factors for asthma and atopic dermatitis in young adult males. Epidemiology. 2000 Mar;11(2):185-8.
Whalley D, Doward LC, Dewar AL, McKenna SP, Tennant A, Emery P. The development of a quality of life measure specific to psoriatic arthritis. Poster presented at the 6th Annual Conference of the International Society for Quality of Life Research (ISOQOL); November 1999. Barcelona, Spain. [abstract] Qual Life Res. 1999 Nov; 8(7):652.
Doward LC, Whalley D, Dewar AL, McKenna SP, Tennant A, Emery P. The development of the SLE-QoL: a quality of life instrument specific to systemic lupus erythematosus. Poster presented at the 6th Annual Conference of the International Society for Quality of Life Research (ISOQOL); November 1999. Barcelona, Spain. [abstract] Qual Life Res. 1999 Nov; 8(7):609.
Sorensen HT, Steffensen FH, Olsen J, Sabroe S, Gillman MW, Rothman KJ, Fischer P. Long-term follow-up of cognitive outcome after breech presentation at birth. Epidemiology. 1999 Sep 1;10(5):554-6.